Free-to-Total Prostate Specific Antigen Ratio as a Single Test for Detection of Significant Stage T1c Prostate Cancer
- 1 September 1996
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 156 (3), 1042-1049
- https://doi.org/10.1016/s0022-5347(01)65696-9
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screeningJAMA, 1995
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995
- The Lack of Predictive Value of Prostate Specific Antigen Density in the Detection of Prostate Cancer in Patients with Normal Rectal Examinations and Intermediate Prostate Specific Antigen LevelsJournal of Urology, 1995
- A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancerJAMA, 1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerJAMA, 1994
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerThe New England Journal of Medicine, 1991
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateThe New England Journal of Medicine, 1987